CLINICAL_TRIALS
trial_result
· 2024-07-24
Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Non-Erosive Reflux Disease [Phase 3]
Summary
Phase 3 trial evaluating the efficacy and safety of BLI5100 in non-erosive reflux disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Braintree Laboratories | Conditions: Non-erosive Reflux Disease | Phase 3 | Status: COMPLETED